A low white cell count that may be Duffy-null (neutrophil count)

Why is my white blood cell count low?

  • Tier B moderate Observed in Black populations
  • Harm signal
  • Last checked
  • Not yet clinically reviewed
Harm signal. The harm is from misreading, not from the variant: 76.5% of 289 recent phase 3 cancer trials excluded neutrophil counts within the Duffy-null range (Hibbs 2024), and a count under 2,000 was found in 24% of Duffy-null healthy adults (Merz 2023), so people can be wrongly treated as unwell or turned away.

The answer

Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection). The main study calls it clinically insignificant. The risk is being misread: a normal count for you can be flagged as low.

What it is

  • An inherited variant: red cells do not carry the Duffy antigen. Common in people of African descent.Tested Merz 2023
  • Not a disease: it gives a lower neutrophil count without raising infection risk.Tested Hibbs 2025

How to find out if you have it

  • A blood test (Duffy testing), done with a full blood count in the main study.Tested Merz 2023
  • A haematology review urges clinicians to use Duffy-null reference ranges, so ask your doctor or a haematologist whether yours applies, especially if your count is low and you are well.Tested Hibbs 2025

What it changes for you

  • Your neutrophil count runs lower than other people: median 2,820 against 5,005 per microlitre in one clinic.Tested Merz 2023
  • Many cancer trials exclude people whose count is in the Duffy-null range.Tested Hibbs 2024
  • Standard cut-offs can wrongly label you neutropenic, which can affect treatment and dosing decisions.Tested Hibbs 2025

What it does not change

  • It does not raise your risk of infection.Tested Hibbs 2025
  • It is not a disease and needs no treatment on its own.Tested Merz 2023

What families do

Tradition and common belief, not evidence.

Nothing is passed down about this; it is a blood-test result, usually met in a clinic. Many Black people have been told a low count is 'normal for your race' or a worry, without the reason being explained.

The evidence

Many people of African ancestry are Duffy-null: in one US clinic two-thirds of 120 healthy Black adults were. Duffy-null people have lower neutrophil counts than other people, and the authors of that study call the difference clinically insignificant. Ask your doctor whether Duffy-null explains a low count before anyone treats it or excludes you from a trial.

This tier rests on: That Duffy-null lowers the neutrophil count without disease: a clinic study of 120, genetic data on 6,005, and a review.

Why this tier and strength: Observational and genetic data in Black populations (n=120 and n=6,005) plus a bibliometric count of trial exclusions; it would move to A if a trial tested outcomes using Duffy-specific cut-offs.

What has been tested

  1. B 120 healthy self-identified Black and African American adults at one US primary care centre (n=120)

    Cross-sectional comparison of neutrophil counts by Duffy phenotype, with Duffy testing.

    66.7% (80 of 120) were Duffy-null. Median absolute neutrophil count was 2,820 cells per microlitre in Duffy-null people against 5,005 in Duffy non-null (P<.001). 23.8% (19 of 80) of Duffy-null people had a count below 2,000, against none of the non-null. The authors state the Duffy-null phenotype is clinically insignificant and advocate Duffy-null-specific reference ranges.

    Merz LE, Story CM, Osei MA, Jolley K et al (2023), Blood Advances, [primary] Open source Study page

    Note: Single centre, n=120; whether the 'clinically insignificant' conclusion holds for all settings is the authors' claim.

  2. B 6,005 African Americans from three cohort studies (n=6005)

    Genetic association analysis.

    The Duffy Null variant (rs2814778) predicted white cell and neutrophil count in African Americans beyond the previously described admixture association, establishing a new phenotype for the variant.

    Reich D, Nalls MA, Kao WH, Akylbekova EL et al (2009), PLoS Genetics, [primary] Open source Study page

  3. B Phase 3 cancer trials for prostate, breast, melanoma, colorectal and lung cancers, 2021-2023 (n=382)

    Cross-sectional analysis of trial exclusion criteria and chemotherapy dose-modification rules.

    Of 289 eligible trials, 221 (76.5%, 95% CI 71.1-81.2) excluded patients whose neutrophil counts were within the Duffy-null reference range. Colorectal trials had the highest exclusion proportion (86.4%), prostate the lowest (47.8%).

    Hibbs SP, Aiken L, Vora K, Mowete C et al (2024), JAMA Network Open, [bibliometric] Open source Study page

  4. B Narrative review (n=not stated)

    Review of Duffy antigen testing, epidemiology, neutrophil counts and clinical consequences.

    The Duffy null variant is a non-pathological mutation that is partly protective against Plasmodium vivax and gives a lower neutrophil count without increasing infection risk. In many regions neutropenia has been defined by the counts of Duffy-positive people, which may be unsuitable for decisions in Duffy-null people.

    Hibbs SP, Jones J, Hantel A, Merz LE (2025), British Journal of Haematology, [review] Open source Study page

  5. B Duffy-null Black people and dose decisions (n=0)

    Search for trial evidence that Duffy-specific reference ranges are safe.

    I found papers on febrile neutropenia in Duffy-null patients with myeloma (Abdallah 2024, abstract not retrievable) and on CDK4/6 inhibitors in breast cancer (Ferri 2025, not opened). I could not confirm trial evidence for safe use of Duffy-specific thresholds. UNVERIFIED.

    Abdallah M, Arters F, Patel J, Edwards C et al (2024), Blood Advances, [primary] Open source Study page

    Note: Title only seen in search; the abstract returned empty from PubMed.

Harm

Signal: The harm is from misreading, not from the variant: 76.5% of 289 recent phase 3 cancer trials excluded neutrophil counts within the Duffy-null range (Hibbs 2024), and a count under 2,000 was found in 24% of Duffy-null healthy adults (Merz 2023), so people can be wrongly treated as unwell or turned away.

Measured variables

  • Duffy phenotype or genotype (rs2814778), a blood test
  • Absolute neutrophil count
  • Self-identified race is a stand-in; Duffy-null also occurs in people of Middle Eastern ancestry (Hibbs 2024 abstract)

Not tested, and gaps

Untested in trials: outcomes (infection, treatment tolerance) when Duffy-null-specific thresholds are used; how often NHS or other labs report Duffy-adjusted ranges. Not verified: the claim of 65% US and 80% UK prevalence (12 Nov research file, via Tsiamita 2025, not opened by me). Duffy testing availability for patients is unverified.

All sources

  • Merz LE et al (2023), Blood Adv, [primary] Open
  • Reich D et al (2009), PLoS Genet, [primary] Open
  • Hibbs SP et al (2024), JAMA Netw Open, [bibliometric] Open
  • Hibbs SP et al (2025), Br J Haematol, [review] Open
  • Abdallah M et al (2024), Blood Adv, [primary] Open

Common questions

Why is my white blood cell count low?

Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection).

What is benign ethnic neutropenia?

Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection).

Is a low neutrophil count normal for Black people?

The risk is being misread: a normal count for you can be flagged as low.

Why was I turned away from a clinical trial for a low neutrophil count?

The risk is being misread: a normal count for you can be flagged as low.

Last checked against its sources: . Next check due: 12 May 2027.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence.